Adhera Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.249; its P/E ratio is >-0.01; Adhera Therapeutics is scheduled to report earnings on May 18, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	$ -347.00K	-	$ 0.00	$ 0.00
Gross Profit	-	$ -347.00K	-	-	-
EBIT	$ 628.00K	$ -199.00K	$ -879.00K	$ -710.00K	$ 773.00K
EBITDA	-	$ 409.00K	$ -335.00K	$ -710.00K	$ 773.00K
Net Income Common Stockholders	$ 245.00K	$ -206.00K	$ -177.00K	$ -1.81M	$ -307.00K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 58.00K	$ 69.00K	$ 32.00K	$ 133.00K	$ 849.00K
Total Assets	$ 82.00K	$ 104.00K	$ 79.00K	$ 256.00K	$ 976.00K
Total Debt	$ 10.59M	$ 9.63M	$ 8.59M	$ 7.99M	$ 7.35M
Net Debt	$ 10.53M	$ 9.56M	$ 8.55M	$ 7.86M	$ 6.50M
Total Liabilities	$ 22.87M	$ 23.20M	$ 22.27M	$ 22.06M	$ 20.97M
Stockholders Equity	$ -22.79M	$ -23.09M	$ -22.19M	$ -21.81M	$ -20.00M
Cash Flow	-
Free Cash Flow	-	$ -310.00K	$ -115.00K	$ -572.00K	$ -474.00K
Operating Cash Flow	$ -316.00K	$ -310.00K	$ -115.00K	$ -572.00K	$ -474.00K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 305.00K	$ 347.00K	$ 52.00K	$ -144.00K	$ 1.28M

Currency in USD

Adhera Therapeutics Earnings and Revenue History

Income Statement >

Adhera Therapeutics Debt to Assets

Balance Sheet >

Adhera Therapeutics Cash Flow

Cash Flow >

Adhera Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing